70 related articles for article (PubMed ID: 10497135)
21. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
22. Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration.
Schauer UM; Völkel W; Dekant W
Toxicol Sci; 2006 May; 91(1):49-58. PubMed ID: 16481339
[TBL] [Abstract][Full Text] [Related]
23. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
24. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E
Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
[TBL] [Abstract][Full Text] [Related]
26. Structural evaluation of the glucuronides of morphine and formoterol using chemical derivatization with 1,2-dimethylimidazole-4-sulfonyl chloride and liquid chromatography/ion trap mass spectrometry.
Salomonsson ML; Bondesson U; Hedeland M
Rapid Commun Mass Spectrom; 2008 Sep; 22(17):2685-97. PubMed ID: 18677706
[TBL] [Abstract][Full Text] [Related]
27. Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects.
Teng R; Oliver S; Hayes MA; Butler K
Drug Metab Dispos; 2010 Sep; 38(9):1514-21. PubMed ID: 20551239
[TBL] [Abstract][Full Text] [Related]
28. Acute and short-term effect of an extra dose of formoterol in COPD patients.
Studart FS; Izbicki M; Nery LE; Oliveira LV; Donner CF; Jardim JR; Nascimento OA
Respir Med; 2012 Jun; 106(6):853-60. PubMed ID: 22336262
[TBL] [Abstract][Full Text] [Related]
29. Metabolism and disposition of moxonidine in Fischer 344 rats.
He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
[TBL] [Abstract][Full Text] [Related]
30. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
31. The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans.
Mannens GS; Hendrickx J; Janssen CG; Chien S; Van Hoof B; Verhaeghe T; Kao M; Kelley MF; Goris I; Bockx M; Verreet B; Bialer M; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):554-65. PubMed ID: 16936066
[TBL] [Abstract][Full Text] [Related]
32. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults.
Eklund A; Tronde A; Johannes-Hellberg I; Gillen M; Borgström L
Biopharm Drug Dispos; 2008 Oct; 29(7):382-95. PubMed ID: 18623040
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
35. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
[TBL] [Abstract][Full Text] [Related]
36. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study.
Aalbers R; Brusselle G; McIver T; Grothe B; Bodzenta-Lukaszyk A
Adv Ther; 2012 Nov; 29(11):958-69. PubMed ID: 23081745
[TBL] [Abstract][Full Text] [Related]
37. A single dose mass balance study of the Hedgehog pathway inhibitor vismodegib (GDC-0449) in humans using accelerator mass spectrometry.
Graham RA; Lum BL; Morrison G; Chang I; Jorga K; Dean B; Shin YG; Yue Q; Mulder T; Malhi V; Xie M; Low JA; Hop CE
Drug Metab Dispos; 2011 Aug; 39(8):1460-7. PubMed ID: 21602311
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic/pharmacodynamic modelling of the eosinopenic and hypokalemic effects of formoterol and theophylline combination in healthy men.
van den Berg BT; Derks MG; Koolen MG; Braat MC; Butter JJ; van Boxtel CJ
Pulm Pharmacol Ther; 1999; 12(3):185-92. PubMed ID: 10419838
[TBL] [Abstract][Full Text] [Related]
39. Metabolism and disposition of vilanterol, a long-acting β(2)-adrenoceptor agonist for inhalation use in humans.
Harrell AW; Siederer SK; Bal J; Patel NH; Young GC; Felgate CC; Pearce SJ; Roberts AD; Beaumont C; Emmons AJ; Pereira AI; Kempsford RD
Drug Metab Dispos; 2013 Jan; 41(1):89-100. PubMed ID: 23043183
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and effects of formoterol fumarate in healthy human subjects after oral dosing.
van den Berg BT; Braat MC; van Boxtel CJ
Eur J Clin Pharmacol; 1998 Aug; 54(6):463-8. PubMed ID: 9776436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
